ESP/IAP 2020 Virtual Congress

Thank you

Thank you for your interest, you may now access the content below.

Highlights from ESMO recommendations outline use of next-generation sequencing in metastatic cancer patients


Nicola Normanno

INT-Fondazione Pascale, Department of Experimental Oncology, Naples
 
Download presentation   Watch symposium

speaker-nicola

Revolutionising the future of precision oncology research with Oncomine Solutions
 


Andy Felton

Vice President Product Management, Thermo Fisher Scientific
 
Download presentation   Watch symposium

speaker-andy

A European inter laboratory research evaluation of Oncomine Precision Assay on Ion Torrent Genexus System

 
Michael Hummel

Pathology Institute Berlin
 
 
 
Download presentation   Watch symposium

speaker-michael

Amplicon based NGS approach for gene fusions analysis from tissue to liquid biopsy
 

 
Umberto Malapelle

Chief Supervisor Predictive Molecular Pathology Laboratory, Department of Public Health, University Federico II of Naples
 
Download presentation   Watch symposium

speaker-umberto



It's NGS, as fast and easy as IHC or PCR

The Oncomine Precision Assay on the Ion Torrent Genexus System features a complete next-generation sequencing (NGS) testing workflow. Now every lab can go from specimen to report in a single day, providing a comprehensive genomic profile at a speed never possible before. This allows you to deliver NGS results at the same time as other single-gene methods, such as immunohistochemistry (IHC) and PDL1 biomarker test. The hands-off, set-up-and-go workflow makes NGS accessible, even if your lab is new to the technology.